Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2025-12-25 @ 2:51 AM
NCT ID:
NCT04302233
Eligibility Criteria:
Inclusion Criteria:
* Patient aged 18 or over
* Patient hospitalized following the scheduled placement of one of the following prostheses: three-compartment knee prostheses or total hip prosthesis or breast implant
* French-speaking or non-French-speaking patient accompanied by a French-speaking support person
* Patient having received complete information and having signed a free and informed consent for the research
* Patient affiliated to a social security scheme (beneficiary or entitled)
Exclusion Criteria:
* Patient having been operated on for the installation of an orthopedic prosthesis not programmed within the framework of a trauma emergency.
* Patient suffering from post-operative confusional syndrome;
* Non-French speaking patient unaccompanied or accompanied by a non-French speaking support person
* Patient on state medical aid
* Persons referred to in articles L1121-5, 6 and 8 of the public health code (corresponds to protected persons): pregnant woman, parturient, nursing mother, person deprived of liberty by judicial or administrative decision, person subject to legal protection measure, hospitalized for psychiatric disorder.
* Patient who has already had postoperative pharmaceutical support for the placement of the same type of prosthesis on the contralateral limb
* Patient suffering from a known cognitive or memory disorder.
* Patient expressly refusing to participate in the telephone interview
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04302233
Study Brief:
Protocol Section:
NCT04302233